The FDA has approved a new pill called Foundayo, also known as orforglipron, for the treatment of obesity. This pill is a GLP-1 medication that can be taken at any time of day without restrictions on food or water. However, the approval comes as the FDA is seeking more safety data, indicating that the full assessment of the pill's effects may not be complete.